Pharmaceutical & Medical Devices
Today’s pharmaceutical and medical device organizations operate amidst a highly competitive marketplace and increasing regulatory and government scrutiny. Drawing on unmatched experience, specialized knowledge and a collaborative, action-oriented approach, Huron has delivered customized financial and operational solutions that have provided significant value for more than 60 leading life sciences companies. 
Pharmaceutical & Medical Devices INSIGHTS
Update: State Reactions to Increasing Drug Prices
On June 3, 2016 Vermont Governor Peter Shumlin signed S.216 into law, which requires pharmaceutical manufacturers to provide justifications for commercial price increases on certain drugs.» MORE

Perspective: Value-Based Contracting: Key Considerations for Life Sciences Manufacturers
Industry trends make a compelling case that we have reached a breaking point, placing the imperative on manufacturers to explore value-based contracts and other novel ways to demonstrate the value of their products.» MORE

Perspective: Part Two: Welcome to Alphabet Soup, Government Pricing, and the Acronyms That Come Along
Part two of this Life Sciences series focuses on the operational requirements of the programs for drug manufacturers in the U.S.» MORE


Related Expertise
PROFESSIONALS
Alt text

David Gilman

Managing Director

Lester Cheng

Lester Cheng

Managing Director

Alt text

Marc Tomassi

Managing Director

Mark Linver

Mark Linver

Managing Director

Paul J. Silver

Paul J. Silver

Managing Director and Practice Leader

Resource

International Medical Device Compliance Code Compendium

First published as a bound reference guide in 2007, the International Medical Device Compliance Code Compendium provides a comprehensive listing of region- and country-level codes of conduct developed by self-regulatory bodies in the medical device sector as well as comparative analyses with the most recent guidance provided by AdvaMed.